Dr. Frank Arguello Cancer Clinic, 2022-04-06: Mexican phase II registration of an 'atavistic chemotherapy' protocol in which ivermectin is one of several anti-protozoal agents combined with antibacterials and antifungals in patients with neoplasms; status unknown, no results.
Nitazoxanide, Chloroquine, Albendazole, Ivermectin, Mebendazole, Metronidazole, Praziquantel, Levamisole
Dr. Frank Arguello Cancer Clinic, 2022-04-06: Mexican phase II registration of an 'atavistic chemotherapy' protocol in which ivermectin is one of several anti-protozoal agents combined with antibacterials and antifungals in patients with neoplasms; status unknown, no results. C1 record field. Country Mexico; phase 2; estimated enrollment 250; start 2011-07-26; status UNKNOWN (last update 2022-04-06); no results. Ivermectin appears only as one agent inside multi-drug arms, and the record gives no ivermectin dose. Registered, no results. Registry entry; no results posted. Study type: regulatory record.
